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Induction of cancer-associated
fibroblast-like cells by carbon
nanotubes dictates its
tumorigenicity
Sudjit Luanpitpong1,2, Liying Wang3, Vincent Castranova2, Cerasela Zoica Dinu4,
Surapol Issaragrisil1, Yi Charlie Chen5 & Yon Rojanasakul2,6
Tumor microenvironment has been recognized as a key determinant of tumor formation and
metastasis, but how tumor microenvironment is affected by nanomaterials is essentially unknown.
Here, we investigated whether carbon nanotubes (CNTs), a widely used nanomaterial with known
carcinogenic potential, can affect cancer-associated fibroblasts (CAFs), which are a key component
of tumor microenvironment that provides necessary support for tumor growth. We show for the first
time that single-walled CNT and to a lesser extent multi-walled and its COOH-functionalized form
induced CAF-like cells, which are non-tumorigenic in animals, but promote tumor growth of human lung
carcinoma and CNT-transformed lung epithelial cells. The mechanism by which CNT-induced CAF-like
cells promote tumor growth involved the acquisition of cancer stem cells (CSCs) in cancer population.
Gene knockdown experiments showed that an expression of podoplanin on CAF-like cells is essential for
their effects, indicating the functional role of CAF-like cells and podoplanin in CNT tumorigenic process.
Our findings unveil a novel mechanism of CNT-induced carcinogenesis through the induction of CAFlike cells that support CSCs and drive tumor formation. Our results also suggest the potential utility of
podoplanin as a mechanism-based biomarker for rapid screening of carcinogenicity of CNTs and related
nanomaterials for their safer design.
Due to their extremely small size, engineered nanomaterials (ENMs) can become airborne, be inhaled, and reach
the pulmonary alveoli of the lungs. A major class of ENMs is carbon nanotubes (CNTs), which have increasingly
been used for a wide variety of applications in fields as diverse as electronics, energy storage, waste treatment,
consumer products, and medicine1,2. With such widespread uses, human exposure is to be expected during manufacturing, incorporation into products, product use and disposal3. Consequently, it is important to determine
their unintended consequences, especially on human health and the environment. CNTs share several properties
(e.g., high aspect ratio and biopersistence) and route of exposure (e.g., inhalation) with asbestos, a known human
carcinogen. Therefore, concern has been raised for the possibility that CNTs would induce an asbestos-like lung
cancer or mesothelioma risk4–6. Several animal studies have indicated the direct and indirect carcinogenic effects
of CNTs, i.e., a single aspiration of single-walled (SW) CNT accelerated metastatic growth of lung carcinoma
in the mouse model of tumor progression7,8, while subacute (15-day) inhalation of multi-walled (MW) CNT
(Mitsui-7) promoted lung adenocarcinoma in the multi-carcinogenesis mouse model9. MWCNT have also been
reported to induce mesothelioma after an intraperitoneal or scrotal injection10–12.
In vitro models have been developed to facilitate high-throughput screening of nanomaterial carcinogenicity
and to aid detailed mechanistic investigations of their pathologic effects. Examples of such models include those
that measure nanomaterials’ ability to malignantly transform cells and to induce cancer stem cells or stem-like
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Source

SWCNT

MWCNT

f-MWCNT

Cheap Tubes Inc.

Cheap Tubes Inc.

Cheap Tubes Inc.
SKU 030113

Catalog reference

SKU 0111

SKU 030111

Synthesis methoda

CCVD

CCVD

CCVD

Primary functionalitya

Pristine

Pristine

COOH (1.8%)

Dry mean width (nm)a

1–2

13–18

13–18

Dry mean length (μm)a

5–30

1–12

1–12

% elemental carbona

>95%

>95%

>95%

% iron impurityb
Other metal impuritiesb

0.12%

Not detectable

N/A

Cr 0.31%

Ni 1.88%

N/A

Co 0.1%

Al 0.04%

Si 0.08%

Si 0.03%

SSA (m2/g)a

>407

>233

>233

Zeta potential (mV)c

−7.44

−9.58

−8.66

Table 1. Physicochemical properties of carbon nanotubes used in this study. aData from manufacturer’s
datasheet. bData from in-house analysis using energy dispersive X-ray spectroscopy (EDX-S). cData from inhouse analysis using Nano Series ZetaSizer. CCVD, plasma purified catalytic chemical vapor deposition. SSA,
specific surface area.
cells (CSCs) upon chronic exposure13,14. Based on our current knowledge and emerging evidence on the role of
the tumor microenvironment in tumor development15–17, we hypothesized that nanomaterials such as CNTs may
induce changes in the tumor microenvironment that support tumor growth. Therefore, we investigated the effect
of CNTs on cancer-associated fibroblasts (CAFs), a key component of the tumor microenvironment known to
regulate tumor growth18,19. Because of their importance in tumorigenesis and metastasis, CAFs have been investigated as a novel target of cancer therapy and as a key contributor of the carcinogenic effect of various agents.
We reported herein that acute exposure of CNTs is capable of activating normal lung fibroblasts to become
CAF-like cells, which have the propensity to promote tumor growth of human lung carcinoma cells and experimentally generated CNT-transformed lung epithelial cells through the mechanisms that involve CSC induction.
With the rapid increase in the utility of nanomaterials20,21 and the lack of specific pre-screening tests for nanomaterial carcinogenicity, we also attempted to develop rapid, mechanism-based, test models and biomarkers based
on their ability to induce CAFs and promote tumorigenesis. Podoplanin was identified as a key protein responsible for the tumor-promoting effect of CNT-induced CAFs and thereby could be a novel candidate biomarker for
initial screening of the carcinogenicity of CNTs and related nanomaterials.

Results

CNT preparation and dose calculations.

All CNTs used in the present study, including SWCNT,
MWCNT and carboxylate (COOH)-functionalized (f )-MWCNT, were obtained from Cheap Tubes Inc.
(Brattleboro, VT) in order to minimize the background differences in source materials and synthesis methods
among samples and their certain physicochemical properties are summarized in Table 1. SWCNT and MWCNT
were investigated in this study because they are the two major types of CNTs, while f-MWCNT may have wider
applications due to its functionality. Prior to use, all CNTs were dispersed in 5% bovine serum albumin (BSA)containing medium by water-bath sonication with the 130 W power, 20 kHz frequency, and 60% amplitude for
10 s as previously described22. Supplementary Figure S1 shows representative scanning electron microscope
(SEM) micrographs of the dispersed CNTs and solid state Fourier transform infrared spectroscopy (FTIR) spectra of pristine MWCNT and f-MWCNT.
The CNT doses used in the in vitro exposure studies were calculated based on in vivo exposure data normalized
to the alveolar surface area in mice and humans23,24. For example, the dose that induced positive in vivo
biological response was 40 μg/mouse lung, which corresponds to 2 mg/kg body weight22,25,26. Dividing this dose by
the average alveolar surface area in mice (~500 cm2)27 indicates the in vitro CNT surface area dose of 0.08 μg /cm2,
which is equivalent to a human lung burden for 8 h/day over 2 years at 400 μg/m3 (high CNT level reported in a
research facility)28 or about 76 years at 10 μg/m3 (average CNT level in U.S. facilities)29.

Effects of CNTs on growth and transformation of primary human lung fibroblasts.

CAFs are
a key component of the tumor microenvironment that provides the necessary support for tumor growth18,19.
To test whether CNTs could induce CAFs and promote tumor formation, we investigated the effect of CNTs on
human lung fibroblasts (LFs) with respect to their ability to induce CAFs and to support tumor growth induced
by human lung carcinoma cells and CNT-transformed lung epithelial cells. Since previous studies have shown
that CSCs are a key driver of tumor formation, and since our recent studies have shown that CNTs could trigger normal lung epithelial cells to initiate CSCs with high tumorigenic potential13,14, we also tested the effect of
CNT-induced CAF-like cells on CSC formation. Primary human LFs were first treated with various concentrations (0–0.15 μg/cm2) of CNTs to determine their general cellular responses and viability using the WST-1
assay. Figure 1A shows that all of the CNTs tested including SWCNT, MWCNT and f-MWCNT had no significant effects on cell proliferation and viability at the concentrations used. These results were confirmed by
CyQuant cell proliferation assay (Invitrogen, Carlsbad, CA) (data not shown). To test whether CNTs can induce
CAFs, the expression levels of known CAF markers, including podoplanin and α-smooth muscle actin (α- SMA),
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Figure 1. Carbon nanotubes induce transformation of primary human lung fibroblasts into cancerassociated fibroblasts. Subconfluent monolayers of human lung fibroblasts were treated with various
concentrations (0–0.15 μg/cm2) of SWCNT, MWCNT, or f-MWCNT for 48 h. (A) Analysis of cell viability
and proliferation using the WST-1 assay. (B) Western blot analysis of the cancer-associated fibroblast marker
podoplanin (PDPN) and myofibroblast marker α-SMA. β-actin was used to confirm equal loading of the
samples. Immunoblot signals were quantified by densitometry, and mean data from three independent
experiments (one of which is shown here) were normalized to the results obtained in cells without CNT
treatment (control). (C) Secreted TGF-βlevels in the culture medium of CNT-treated lung fibroblasts as
determined by ELISA. Data are mean ±  SD (n =  3). *P <  0.05 vs. vehicle-treated control cells. #P <  0.05 vs
SWCNT-treated cells.

a prototypic marker of myofibroblasts known to be enriched in CAFs19,30,31, were examined in CNT-treated
human lung fibroblasts using Western blot analysis. Figure 1B shows that SWCNT, and to a lesser extent MWCNT
and f-MWCNT, induced the CAF markers podoplanin and α-SMA. Additionally, the increase in secreted TGF-β,
which represents a major cytokine released from CAFs32,33, was observed in response to CNT treatment (Fig. 1C)
in concomitant with the upregulation of podoplanin, suggesting that CNTs were able to induce CAF-like cells, the
finding that is supported by subsequent studies on tumor formation.

CNT-induced CAF-like cells promote tumor formation.

It has been shown in the previous study19
and validated in the present study that co-injection of untreated LFs could promote the growth of human lung
carcinoma xenograft tumors in vivo (Supplementary Figure S2A). To investigate the tumor-promoting effect of
CAF-like cells induced by CNTs, we co-injected mice subcutaneously (SC) with CNT-induced CAF-like cells
(LF/SWCNT) or with vehicle-treated lung fibroblasts (LF/BSA) and human lung carcinoma H460 cells at 2:1
ratio, as schematically depicted in Fig. 2A. To aid quantitation of tumor formation and growth, the lung carcinoma H460 cells were genetically modified to express luciferase (LUC2) for highly sensitive and non-invasive
detection of tumor growth by bioluminescence imaging (IVIS Lumina II, PerkinElmer, Waltham, MA). Tumor
luminescence signals were quantified over time and normalized to their initial signals at the time of inoculation
(day 0). Figure 2B and C shows that tumor luminescence was substantially higher in the mice bearing H460
cells with LF/SWCNT cells, as compared to the mice bearing H460 cells with control LF/BSA cells, indicating
the tumor-promoting effect of CNT-induced CAF-like cells. Direct measurements of tumor weight at the end
of experiments (week 3) similarly indicated a marked increase in the excised tumor weight in mice treated with
H460 cells and LF/SWCNT cells as compared to control treatment (Fig. 2D).
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Figure 2. Carbon nanotube-induced cancer-associated fibroblast-like cells promote tumor formation of
human lung carcinoma H460 cells. (A) Schematic diagram depicting methodological steps of in vivo and in vitro
co-culture experiments. (B) SWCNT-induced cancer-associated fibroblast-like cells (LF/SWCNT) or vehicletreated fibroblasts (LF/BSA) at the dose of 6 ×  105 cells were co-injected with luciferase-labeled H460 cells at the
dose of 3 ×  105 cells (2:1 ratio) into the left and right flanks of NSG mice. Tumor formation was monitored weekly
by IVIS bioluminescence imaging. IVIS images of mice at day 0 and week 3 are shown. (C) Normalization of
tumor bioluminescence signals at various time points post-injection to their initial signals at day 0. (D) Subcutaneous
tumors were dissected from mice bearing H460 and LF/SWCNT or LF/BSA, and weighted at the end of
experiments at 3 weeks post-injection. Data are mean ± SD (n =  4). *P <  0.05 vs H460 and LF/BSA group.

To test whether CNT-induced CAF-like cells could similarly promote tumor cell growth in vitro, we
co-cultured CNT-induced CAF-like cells with lung carcinoma H460 cells, as schematically depicted in Fig. 2A,
and evaluated for their colony growth under soft agar assay, which is the most stringent indicator for malignant
Scientific Reports | 6:39558 | DOI: 10.1038/srep39558
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Figure 3. Carbon nanotube-induced cancer-associated fibroblast-like cells promote the growth and
maintenance of cancer stem cells. Carbon nanotube-induced cancer-associated fibroblast-like cells (LF/SWCNT
or LF/f-MWCNT) or vehicle-treated fibroblasts (LF/BSA) were co-cultured with GFP-labeled lung cancer H460
cells (2:1 ratio). (A) Analysis of soft agar colonies after 2 weeks of culture. Scale bar =  200 μm. (B) Analysis of
tumor sphere formation after 2 weeks of culture. Scale bar =  300 μm. Data are mean ± SD (n =  4). *P <  0.05 vs
H460 and LF/BSA group. #P <  0.05 vs H460 and LF/SWCNT group.

transformation associated with anchorage independence. Figure 3A shows that larger colonies were observed
in the presence of SWCNT-induced CAF-like cells in a dose-dependent manner as well as in the presence of
f-MWCNT-induced CAF like cells. These results strongly support the tumor-promoting effect of CNT-induced
CAF-like cells.
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CNT-induced CAF-like cells promote CSCs. CSCs represent a subpopulation of cells in solid tumors that

drive tumor initiation and progression due to their ability to self-renew and generate differentiated malignant
progeny34,35. To test whether CNT-induced CAF-like cells could promote tumor formation through the activation
of a CSC niche, we co-cultured CNT-induced CAF-like cells with human lung carcinoma H460 cells and analyzed
CSC generation by measuring tumor sphere formation, a functional assay for CSC formation under selective condition of serum-free media and non-adherence, and side population (SP). To determine the effect of microenvironment on CSC growth, we first tested the influence of LFs on CSC tumor spheres. In accordance with previous
in vivo tumor formation results, the presence of untreated LF cells was shown to support the growth of lung CSC
spheres (Supplementary Figure S2B). While we found that CNT-induced CAF-like cells alone minimally survived
(Supplementary Figure S2C), co-culture of them (LF/SWCNT and LF/f-MWCNT) with lung carcinoma H460
cells resulted in a greater number of large tumor spheres when compared to the co-culture of H460 cells and
control LF/BSA cells (Fig. 3B).
Likewise, SP analysis, which is a flow cytometric measurement commonly used to assess of the ability of CSCs
to efflux Hoechst 33342 dye due to their high ABCG2 expression36,37, indicated an increase in the CSC proportion in the H460 cell population, which have been modified to express green fluorescence protein (GFP) to aid
their identification, when co-cultured with CNT-induced CAF-like cells (LF/SWCNT and LF/f-MWCNT) as
compared to control (LF/BSA) (Fig. 4A). We also observed an increase in lung CSC marker CD133 level in the
co-culture of H460 cells and CNT-induced CAF-like cells (Fig. 4B). Together, these results indicate the ability of
CNT-induced CAF-like cells to provide a supportive microenvironment for CSC growth and maintenance.

Podoplanin as a mechanism-based biomarker for CNT tumorigenicity. To further investigate the
role of CNT-induced CAF-like cells in the tumor formation of lung cancer cells and to develop a potential predictive biomarker for CNT carcinogenicity, we evaluated the functional role of podoplanin in the tumor-promoting
effect of CNT-induced CAF-like cells. Podoplanin, also known as Gp36, is a transmembrane siaglycoprotein
that is expressed in CAFs of cancerous stroma and has been identified as a new marker of CAFs in various
cancers, including lung19,38. Primary human LFs were stably transfected with short-hairpin (sh) RNA plasmid
against podoplanin (shPDPN) or control vector (shCON), and their effects on CSC formation and tumorigenesis of lung cancer cells were examined. Figure 5A shows that the shPDPN-transfected fibroblasts expressed a
substantially lower level of both basal and CNT-induced podoplanin expression than the shCON-transfected
cells. These knockdown and control cells were used to examine the functional role of podoplanin in CSC formation and tumorigenesis by in vitro tumor sphere formation and in vivo xenograft tumor formation assays,
respectively. Figure 5B shows that the podoplanin-knockdown cells, either CNT-treated (shPDPN-LF/SWCNT,
shPDPN-LF/f-MWCNT) or vehicle-treated (shPDPN-LF/BSA), were relatively ineffective in inducing CSCs from
the human lung carcinoma H460 cells, as compared to vector-transfected control cells (shCON-LF/SWCNT,
shCON-LF/f-MWCNT). Likewise, in vivo tumorigenesis studies showed that co-injection of CNT-treated
podoplanin-knockdown cells with lung carcinoma H460 cells yielded a lower level of tumor-associated luminescence signals (Fig. 6A and B). Direct measurements of the tumor weight from the treated animals confirmed the
finding (Fig. 6C). These results indicate that podoplanin is crucial to the tumor-promoting effect of CNT-induced
CAF-like cells, and their CSC-enhancing activity. These results also suggest that podoplanin may be used as a
potential biomarker for CNT carcinogenicity.
CNTs provoke a specific CSC niche for lung tumorigenicity.

Increasing evidence suggests that certain types of CNTs are carcinogenic7–12,39,40. Although the mechanism underlying this carcinogenicity remains
incompletely understood, an induction of CSCs by CNTs has been implicated13,14. Based on our finding in the
present study showing the induction of CSCs from human lung carcinoma cells by CNT-induced CAF-like cells,
we further investigated whether these CAFs can also induce CSCs from CNT-transformed human lung epithelial cells, and whether or not such induction is dependent on podoplanin. First, CNT-induced CAF-like cells
(LF/SWCNT and LF/f-MWCNT) were co-cultured with human lung epithelial cells that had been previously transformed by chronic exposure to CNTs (BEAS-2B/SWCNT) as previously described13,14,40. These
CNT-transformed cells were shown to be tumorigenic and contain CSC subpopulation13,14, which were further
investigated in this study to examine the impact of CAF-like cells on their CSC- and tumor-forming capacities.
Figure 7A shows that CNT-induced CAF-like cells indeed increased the level of CSC subpopulation in the transformed epithelial cell population as determined by tumor sphere formation assay. Interestingly, knockdown of
podoplanin in the CNT-induced CAF-like cells completely inhibited their effect on CSC formation (Fig. 7A), consistent with the earlier finding in H460 cells and supporting the functional role of podoplanin in CSC regulation.
Next, we determined the effect of CNT-induced CAF-like cells on tumor formation of CNT-transformed lung
epithelial (BEAS-2B/SWCNT) cells in mice. Figure 7B and C shows that the CAFs were able to promote tumor
growth of the CNT-transformed lung epithelial cells. These results indicate that CNTs are capable of not only
transforming lung epithelial cells to become tumorigenic but also altering their microenvironment by inducing
CAF-like cells that support tumor growth.

Discussion

Lung cancer is the leading cause of cancer mortality and is strongly associated with environmental and occupational exposure41,42. Due to their extremely small size and respirable nature, nanoparticles are a prime candidate for lung cancer risk. Analysis of environmental nanoparticles revealed that there could be between
20,000–100,000 nanoparticles/cm3 in the atmosphere, with a significant fraction being CNTs43,44. Considering
concerns over the increasing utility of CNTs and their potential health hazards, the objective of this study was to
investigate cancer-related pathologies and the underlying mechanisms in order to develop biomarkers and rapid
assessment tools for carcinogenicity testing of nanomaterials and to aid safe-by-design efforts. In the context of
Scientific Reports | 6:39558 | DOI: 10.1038/srep39558
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Figure 4. Analysis of side population and lung stem cell marker CD133 in lung carcinoma cells cultured
with carbon nanotube-induced cancer-associated fibroblast-like cells. Carbon nanotube-induced cancerassociated fibroblast-like cells (LF/SWCNT or LF/f-MWCNT) or vehicle-treated fibroblasts (LF/BSA) were
co-cultured with GFP-labeled lung cancer H460 cells (2:1 ratio). (A) Analysis of side population (SP) of the
GFP-labeled H460 cells in the presence or absence of fumitremorgin c (FTC) using FACS. SP cells (box) are
determined by their disappearance in the presence of FTC. (B) Western blot analysis of lung stem cell marker
CD133 in the co-culture of H460 cells with LF/BSA, LF/SWCNT or LF/f-MWCNT cells.

carcinogenesis, any substances that act on one or more stages of tumor initiation, promotion and progression
are considered carcinogens45,46. Carcinogens exert their effects on cells and tissues in two ways: (i) direct effects
on target cells, i.e., by causing DNA mutation and oncogene activation; and (ii) indirect effects on neighboring
cells that comprise the tumor microenvironment and are required for tumor growth and development. These
two mechanisms generally work in concert to produce the carcinogenic effect caused by an agent. With regard
to CNTs, we have previously demonstrated that chronic exposure to certain CNTs induced malignant transformation and tumorigenesis of human lung epithelial cells13,14,39,40. However, the role of tumor microenvironment and the mechanism by which it regulates the tumorigenesis are not known. In this study, we demonstrated
for the first time that CNTs, notably SWCNT and to a lesser extent MWCNT and f-MWCNT, activated LFs
to become CAF-like cells, which are the key component of the tumor microenvironment that supports tumor
growth (Fig. 1). These CNT-induced CAF-like cells were shown to promote tumor formation of human lung
carcinoma H460 cells (Fig. 2) and CNT-transformed lung epithelial cells (Fig. 7) in a xenograft mouse model.
These cells, however, did not induce tumor formation on their own, indicating the supporting role of CAF-like
cells in the tumor development (data not shown). These results are consistent with the earlier reports showing
the modulation of the tumor microenvironment by CNTs that promotes tumor growth. For example, a single
pharyngeal aspiration of SWCNT in mice was shown to induce an accumulation of myeloid-derived suppressor
Scientific Reports | 6:39558 | DOI: 10.1038/srep39558
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Figure 5. Carbon nanotube-induced cancer associated fibroblast-like cells are incapable of inducing cancer
stem cells in the absence of podoplanin. (A) Human lung fibroblasts were stably transfected with shRNA
plasmid against podoplanin (shPDPN) or scramble control (shCON), and treated with SWCNT, MWCNT or
f-MWCNT at the dose of 0.15 μg/cm2 for 48 h. Podoplanin level was detected by Western blotting. (B) Carbon
nanotube-induced cancer-associated shCON fibroblast-like cells (shCON-LF/SWCNT or LF/f-MWCNT)
or carbon nanotube-treated shPDPN fibroblast-like cells (shPDPN-LF/SWNCT or LF/f-MWCNT) were cocultured with H460 cells (2:1 ratio), and tumor sphere formation was analyzed after 2 weeks of culture. Scale
bar =  200 μm. Data are mean ±  SD (n =  4). *P <  0.05 vs H460 and shCON-LF/BSA group. §P <  0.05 vs CNTtreated shCON group. #P <  0.05 vs shCON-LF/SWCNT group.

cells in the lungs that resulted in host immunosuppression and lung carcinoma acceleration7,8. The detection of
CNT-induced CAF-like cells could be beneficial over the previously reported CNT-induced lung epithelial cell
transformation in view of its rapid response to CNT stimuli (e.g. within 48 h), making it a feasible method for
pre-screening of possible CNT carcinogens for further detailed analyses, e.g. in chronic exposure studies.
It is widely accepted that certain physicochemical properties affect CNT bioactivities, including fibroblastic responses. The greater capability of SWCNT to activate CAF-like cells over MWCNT in the present study
is consistent with previous studies indicating that SWCNT induced greater interstitial pulmonary fibrosis and
collagen deposition in vivo47,48 and induced higher fibroblast stem-like cells and 3D-fibroblastic nodules that
resembled clinical fibroblastic foci in vitro24. With respect to functionalization of CNTs, conflicting results have
been reported. While several studies indicated that COOH functionalization significantly decreased CNT bioactivities, e.g. fibrogenic responses and pulmonary inflammation49–52, we and some others observed an increase in
cytogenic, genotoxic and fibrogenic activities by COOH functionalization53,54. In the present study, f-MWCNT
elicited more robust effects on CAF-like cells and CSCs as compared to MWCNT. Thus, the relative potency
is summarized as SWCNT > f-MWCNT >MWCNT. Notably, variations in experimental conditions and
assay methods may account for the observed inconsistencies and more experimental data on the in vivo CNT
Scientific Reports | 6:39558 | DOI: 10.1038/srep39558
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Figure 6. Podoplanin is required for the tumor promoting effect of carbon nanotube-induced cancerassociated fibroblasts. (A) Carbon nanotube-induced cancer-associated shCON fibroblast-like cells (shCON/
SWCNT) or carbon nanotube-treated shPDPN fibroblast-like cells (shPDPN/SWCNT) at the dose of 6 ×  105
cells were co-injected with luciferase-labeled H460 cells at the dose of 3 ×  105 cells (2:1 ratio) into the left and
right flanks of NSG mice. Tumor formation was monitored weekly by IVIS bioluminescence imaging. IVIS
images of mice at day 0 and week 2 and 3 are shown. (B) Normalization of tumor bioluminescence signals at
various time points post-injection to their initial signals at day 0. (C) Subcutaneous tumors were dissected from
mice bearing H460 and LF/SWCNT or LF/BSA, and were weighted at the end of experiments at 3 weeks postinjection. Data are mean ±  SD (n =  4). *P <  0.05 vs H460 and shCON/SWCNT group.
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Figure 7. Carbon nanotube-induced cancer-associated fibroblast-like cells and podoplanin level are
associated with tumorigenicity of carbon nanotube-transformed cells. (A) Carbon nanotube-induced
cancer-associated shCON fibroblast-like cells (shCON-LF/SWCNT or LF/f-MWCNT) or carbon nanotubetreated shPDPN fibroblast-like cells (shPDPN-LF/SWCNT or LF/f-MWCNT) were co-cultured with SWCNTtransformed lung epithelial BEAS-2B/SWCNT cells (2:1 ratio), and tumor sphere formation was analyzed
after 2 weeks of culture. Scale bar =  200 μm. (B) Carbon nanotube-induced cancer-associated fibroblast-like
cells (LF/SWCNT) or vehicle-treated fibroblasts (LF/BSA) were co-injected with SWCNT-transformed lung
epithelial BEAS-2B/SWNCT cells (2:1 ratio) into the left and right flanks of NSG mice. Tumor formation was
monitored weekly by IVIS bioluminescence imaging. Normalization of tumor bioluminescence signals at
various time points post-injection to their initial signals at day 0. (C) Subcutaneous tumors were dissected from
mice bearing BEAS-2B/SWCNT and LF/SWCNT or LF/BSA, and were weighted at the end of experiments at
3 weeks post-injection. Data are mean ±  SD (n =  4). *P <  0.05 vs H460 and shCON-LF/BSA group. §P <  0.05 vs
CNT-treated shCON group. #P <  0.05 vs shCON-LF/SWCNT group.

carcinogenicity are needed to substantiate these effects. In addition to affecting normal tumor cells, increasing
evidence also indicates that the tumor microenvironment regulates CSCs that drive tumorigenesis. In fact, the
severity or aggressiveness of specific cancer types, including lung cancer, is frequently associated with their CSC
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population14,34,36. Furthermore, the carcinogenicity of several environmental and occupational carcinogens, such
as tobacco, arsenic, and CNTs, has been linked to their CSC inducing capability13,55,56. In this study, we observed
an induction of CSCs by CNT-induced CAF-like cells (Fig. 3), supporting the role of these CAF-like cells in the
CSC growth and maintenance. This finding is consistent with other recent reports showing the importance of
CAFs in controlling the plasticity of cancer stemness18,57. CAFs were shown to regulate the growth of CSCs in a
paracrine manner via the insulin-like growth factor (IGF)-II/IGF1 receptor (IGF1R)/Nanog signaling pathway18.
Interestingly, we found that CNT-induced CAF-like cells promoted the growth of CNT-transformed lung epithelial cells and their CSC subpopulation (Fig. 7), indicating that CNTs are capable of exerting multiple effects
on different cell types, i.e., by causing transformation of normal LFs into CAF-like cells, lung epithelial cells into
malignant cells, and by regulating CSCs that could serve as a continuous source of cancer cells.
One of the key goals of this study was to develop a mechanism-based biomarker for carcinogenicity testing
and risk assessment of nanomaterials. We identified podoplanin as a potential biomarker based on its robust
upregulation by CNTs and its functional role in tumorigenesis. Downregulation of podoplanin in LFs by RNA
interference strongly inhibited CNT-induced CAF-like cells and their effects on CSCs and subsequent tumor
formation (Figs 5, 6 and 7), providing new insights into the role of podoplanin in CSC growth and maintenance mediated by CAF-like cells. Our findings also highlight the importance of podoplanin as a predictive
biomarker for CNT-induced carcinogenesis. Increasing evidence indicates that podoplanin has a prognostic significance for different types of tumors38. In lung cancer, the presence of podoplanin-positive CAFs predicted
advanced pathological stage, e.g. the presence of lymph node metastasis as well as vascular and pleural invasion,
and poor outcome among patients with adenocarcinoma and squamous cell carcinoma58–60. A recent findings
showed that podoplanin assisted lung tumor cells with local invasion; that is tumor cells invaded by following the
podoplanin-positive CAFs into surrounding extracellular matrix through RhoA activation61. It is worth noting
that podoplanin expression was associated with a history of smoking38, which might be linked to the mechanism of lung carcinogenesis. The potential advantages of podoplanin as a biomarker include: (i) its rapidity of
detection, i.e., the induction of podoplanin by CNTs can be detected within 48 h after exposure; (ii) potential for
high-throughput screening assay allowing analysis of a large number of samples with a fewer number of cells per
assay, i.e., by using high-content imaging or in-cell Western assays; and (iii) its functional importance and clinical
relevance, i.e., podoplanin expression in CAFs has been shown to correlate with poor prognosis and decreased
survival of lung cancer patients as earlier mentioned.
In conclusion, we have provided novel evidence, as schematically summarized in Fig. 8, that CNTs can induce
CAF-like cells that promote CSC formation in lung epithelial cells. Since CSCs are shown to be a key driver of
tumorigenesis, our finding concerning CSC induction by CNT-derived CAF-like cells offers a new insight into
the possible mechanism of CNT-induced carcinogenesis. Due to its elevated expression and requirement for CSC
induction and tumorigenesis, we suggest that podoplanin may be used as a predictive biomarker for cancer risk
assessment and for safer by design screening of CNTs and related nanomaterials.

Materials and Methods

Cell culture and CNT exposure.

Primary normal human LFs were obtained from Lonza (Walkersville,
MD) and were cultured in FGM-2 medium containing 2% fetal bovine serum (FBS), 0.1% human basic fibroblast growth factor, 0.1% insulin and 0.1% gentamicin (Lonza). Early-passage cells (p < 6) were seeded (5 ×  105
cells/well) in 6-well plate and exposed to lightly sonicated, BSA-dispersed CNTs (Cheap Tubes Inc.), including
SWCNT, MWCNT and f-MWCNT at various concentrations for 48 h. Vehicle-only exposed cells were used as a
control. Non-small lung cancer cell (NSCLC)-H460 cells were obtained from American Type Culture Collection
(ATCC; Manassas, VA) and were cultured in RPMI 1640 medium supplemented with 5% FBS, 2 mM L-glutamine,
and 100 units/mL penicillin and 100 μg/mL streptomycin (P/S). Human bronchial epithelial BEAS-2B cells were
obtained from ATCC and were chronically exposed to low-dose SWCNT (0.02 μg/cm2) for 6 months to generate
BEAS-2B/SWCNT cells as previously described13,14,40. They were cultured in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 5% FBS, 2 mM L-glutamine and P/S. All cells were maintained in a humidified
atmosphere of 5% CO2 at 37 °C.

Cell viability assay.

Cell viability was determined using WST-1 assay kit (Roche Molecular Biochemicals,
Indianapolis, IN, USA) following the manufacturer’s instructions. Cells were seeded (1 ×  104 cells/well) in quadruplicate in 96-well plates in culture medium and were exposed to various concentrations (0–0.15 μg/cm2) of
SWCNT, MWCNT or f-MWCNT for 48 h. The cells were then incubated with WST-1 reagent and incubated for
an additional 4 h. The absorbance was measured at 450 nm using a microplate reader (FLUOstar OPTIMA, BMG
Labtech, Durham, NC) and relative cell viability was calculated by dividing the absorbance of the treated cells by
that of the control (non-treated) cells.

Western blot analysis.

After specific treatments, cells were incubated in a commercialized lysis buffer
(Cell Signaling Technology, Beverly, MA) and a protease inhibitor mixture (Roche Molecular Biochemicals,
Indianapolis, IN) at 4 °C for 20 min. The cell lysates were collected and determined for protein content using
the Pierce BCA protein assay (Pierce Biotechnology, Rockford, IL). Proteins (40 μg) were resolved under denaturing conditions by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes (Invitrogen, Carlsbad, CA). The transferred membranes were blocked for 1 h in
5% nonfat dry milk in TBST (25 mM Tris–HCl, pH 7.4, 125 mM NaCl, 0.05% Tween 20) and incubated with the
appropriate primary antibodies, i.e. anti-podoplanin (ABT34; Millipore, Billerica, MA) or anti-α-SMA (ab5694;
Abcam, Cambridge, MA), at 4 °C overnight. Membranes were washed twice with TBST for 10 min and incubated
with horseradish peroxidase-coupled isotype-specific secondary antibodies for 1 h at room temperature. The
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Figure 8. A schematic working model for the roles of carbon nanotubes in tumor promotion. Carbon
nanotubes can induce cancer associated fibroblast-like cells that promote cancer stem cell formation in lung
epithelial cells.

immune complexes were detected by an enhanced chemiluminescence detection system (Amersham Biosciences,
Piscataway, NJ) and quantified using analyst/PC densitometry software (Bio-Rad Laboratories, Hercules, CA).

TGF-β enzyme-linked immunosorbent assay (ELISA). Cells were seeded (2 ×  105 cells/well) in triplicate in 6-well plates in culture medium and were exposed to various concentrations (0–0.15 μg/cm2) of SWCNT,
MWCNT or f-MWCNT for 48 h. Cell supernatants were then collected and analyzed for TGF-βby ELISA using a
commercial kit (R&D Systems, MN). Briefly, cell supernatant samples or reference standards (100 μL) were added
to the wells of a microplate that was pre-coated with TGF-βmonoclonal antibody and incubated for 2 h at room
temperature. After washing unbounded substances, a HRP-conjugated polyclonal antibody against TGF- β was
added to the wells and incubated for 2 h at room temperature. After washing and addition of 100 μL of substrate
solution, optical density was determined on a microplate reader (FLUOstar OPTIMA BMG LABTECH Inc.,
Durham, NC, USA) at 450 nm.
Xenograft mouse model.

Animal care and experimental procedures described in this study were performed in accordance with the Guidelines for Animal Experiments at West Virginia University and were approved
by the Institutional Animal Care and Use Committee (IACUC #12–0502). Immunodeficient NOD/SCID gamma
mice, strain NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG; Animal Models and Imagining Facility, Mary Babb Randolph
Cancer Center, Morgantown, WV), were maintained under pathogen-free conditions within the institutional
animal facility62. Food and tap water were given ad libitum. Mice were subcutaneously injected with 6 ×  105
CNT-exposed LFs and 3 ×  105 luciferase (LUC2)-labeled H460 or BEAS-2B/SWCNT cells (2:1 ratio) suspended
in 100 μL of ExtraCel hydrogel (Advanced BioMatrix, San Diego, CA). Tumor growth of luciferase-labeled cells
was monitored weekly using IVIS bioimaging system (PerkinElmer, Waltham, MA). For quantitative comparison,
normalized flux was calculated by diving the luminescence flux signal at a given time by that of the signal at the
time of inoculation. At the end of experiments, mice were euthanized by carbon dioxide inhalation, and subcutaneous tumors were dissected and weighted.
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Plasmids and transfection.

GFP plasmid was obtained from Invitrogen (Carlsbad, CA), while shRNA
plasmids against human PDPN (shPDPN) and scrambled vector (shCON) were obtained from SABiosciences
(SureSilencingTM, Frederick, MD). For transfection, 1 ×  106 cells were suspended in 100 μL of nucleofection solution with 2 μg of plasmid and nucleofected using Nucleofector (Amexa Biosystems, Cologne, Germany) with the
device program T020 for H460 and BEAS/SWCNT and program U 023 for LFs. The cells were then resuspended
in 500 μL of complete medium and seeded in 60-mm cell culture dishes. The cells were allowed to recover for 48 h
before each experiment and were sorted for GFP-positive cells using a BD FACSAria cell sorter (BD Biosciences,
San Jose, CA).

®

SP analysis. Cells were detached by trypsinization, and 1 ×  106 cells were labeled with 5 μg/mL of Hoechst
33342 in DMEM-F12 medium containing 2% FBS in the presence or absence of 25 μM ABCG2 inhibitor fumitremorgin C (FTC; EMD Biosciences, San Diego, CA) at 37 °C for 90 min. The cells were then centrifuged and
resuspended in ice-cold Hank’s buffer salt solution (HBSS). SP analysis and sorting were performed using a BD
FACSAria cell sorter (BD Biosciences, Franklin Lakes, NJ). The Hoechst dye was excited with a UV laser and
its fluorescence was measured with both a 450/20 filter (Hoechst Blue) and 675 LP filter (Hoechst Red). The SP
fraction was calculated based on the disappearance of SP cells in the presence of FTC using the formula: SP percentage in the absence of FTC − SP percentage in the presence of FTC.
Soft agar colony formation. Soft agar assay was performed as previously described13. CNT-exposed LFs
(2 ×  104 cells) and H460 or BEAS-2B/SWCNT cells (1 ×  104 cells) were mixed with culture medium containing
0.5% agar to a final agar concentration of 0.33% at 2:1 ratio. Cell suspensions were immediately plated onto dishes
coated with 0.5% agar in culture medium. Large (>50 μm) colonies were examined under a light microscope after
two weeks of culture.
Tumor sphere assay.

Tumor sphere assay was performed under non-adherent and serum-free conditions as previously described as stem cell-selective conditions37. Briefly, 1 ×  104 CNT-exposed LFs and 5 ×  103
H460 or BEAS-2B/SWCNT cells (2:1 ratio) were resuspended in 0.8% methylcellulose (MC)-based serum-free
medium (Stem Cell Technologies, Vancouver, Canada) supplemented with 20 ng/mL epidermal growth factor
(BD Biosciences), basic fibroblast growth factor and 4 mg/mL insulin (Sigma). The cell suspension was plated
in ultralow adherent 24-well plates (Corning, Corning, NY) and cultured for two weeks. Large (>50 μm) tumor
spheres were quantified under a light microscope.

Statistical analysis. The data represent means ± SD from three or more independent experiments as indicated. Statistical analysis was performed by Student’s t test at a significance level of P < 0.05. An ANOVA followed
by Mann-Whitney U test was used for a multiple pairwise comparison.
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